腫瘍特異性抗原の発現は,がん免疫編集の基礎となっている
Michel DuPage1, Claire Mazumdar, Leah M Schmidt
1Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Nature
|February 10, 2012
まとめ
癌の免疫編集は,敏感な細胞を排除することによって,腫瘍から保護します. この研究は,リンパ球による腫瘍抗原認識が編集に不可欠であり,免疫性がんが少なくなることを示しています.
科学分野:
- 免疫学 免疫学とは
- 腫瘍学 腫瘍学
- がん研究 がん研究
背景:
- 癌の免疫エディティングは,適応性免疫細胞が発達中の腫瘍を排除することを含む.
- 腫瘍細胞は,免疫攻撃に対する抵抗性を進化させ,がんの進行に影響を与える可能性があります.
- 以前のモデルは,腫瘍の異質性により課題に直面していました.
研究 の 目的:
- 遺伝子工学による原住民マウスモデルを使用してがんの免疫編集を調査する.
- 同様の遺伝的背景を持つ免疫原性および非免疫原性腫瘍を比較する.
- サルコマ免疫編集における腫瘍抗原のリンパ球認識の役割を明らかにする.
主な方法:
- 遺伝子組み換えマウスモデルを用いて,先住民のサルコマゲネシスを研究した.
- 腫瘍の発生と成長をインサイトで監視した.
- 免疫能力のあるマウス,免疫欠乏症マウス,抗原耐性マウスにおける腫瘍発達の比較.
主要な成果:
- 腫瘍特異性抗原のリンパ球の認識は,サルコマに対する免疫編集に不可欠です.
- プライマリーサルコマは,免疫逃避性細胞の増殖によって,免疫原性細胞が少なくなるように編集された.
- 腫瘍抗原発現またはMHC Iプレゼンテーションの喪失は,免疫脱出に十分であった.
結論:
- 腫瘍特異性抗原発現は,免疫監視と潜在的な免疫療法に不可欠です.
- 免疫編集は,Tリンパ球媒介による破壊を逃れる腫瘍細胞の変種を選択します.
- これらのメカニズムを理解することで,新たながん治療戦略を策定することができます.
関連する概念動画
lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


